BTI - British American Tobacco p.l.c.
Three household income names blended into a single portfolio promise a quiet monthly paycheck, but one just cut its distribution, another carries a tax trap most investors miss, and the principal you think you are protecting may already be moving.
British American Tobacco's Modern Oral segment grew 65.9% in H1'26 and is now the company's largest New Category while holding a 39.2% volume share in top markets. Sweden, Norway, Poland, and the US show how oral nicotine expands the pool of users as cigarettes decline. A reverse DCF shows that the shares at $55 look to price Modern Oral at a mere 16% CAGR, while this segment has been compounding at 47-66% recently.
British American Tobacco offers compelling value trading at 11.5x forward earnings with a 6% dividend yield. NGP revenue grew 18% YoY, with Velo now the global leader in Modern Oral and strong U.S. market share gains. Management guides for 5–8% adjusted EPS growth in 2026, supported by NGP momentum and improving profitability.
Federal Hemp Framework and Healthcare Strategy Advance; Debenture Conversion Eliminates Largest Liability, Restores Positive Shareholders' Equity; Gross Margin Expands to 47.5% and Second Quarter Operating Cash Use Reduced to $0.9M Louisville, Colorado--(Newsfile Corp. - August 13, 2026) - Charlotte's Web Holdings, Inc. (TSX: CWEB) (OTCQX: CWBHF) ("Charlotte's Web" or the "Company"), a botanical wellness innovation company and the market leader in cannabidiol (CBD) hemp extract wellness products, today announced results for the quarter ended June 30, 2026. All amounts are expressed in U.S. dollars unless otherwise indicated.
At the 24% federal bracket, a $50,000 stream of ordinary dividend income hands roughly $12,000 to the IRS every year.
BANGALORE, India & LONDON--(BUSINESS WIRE)---- $ITC #AI--ITC Infotech today announced a landmark multi-year strategic technology deal with British American Tobacco (BAT).
British American Tobacco remains a 'hold' as deteriorating fundamentals and limited upside outweigh growth in modern oral products. BTI's New Categories, particularly Velo and Vuse, are delivering strong market share gains, but core combustibles face long-term decline. Despite revenue growth, net income and EBITDA declined; cost-cutting and share buybacks are central to management's strategy.
British American Tobacco p.l.c. (BTI) Q2 2026 Earnings Call Transcript
For British American Tobacco p.l.c., like for tobacco companies, transitioning into next-generation nicotine products is key. And in this regard, the company made gains in H126. Its new categories segment saw both increased revenue contribution, accelerated revenue growth, a bigger contribution margin, and even the vaping business turned around after two years. While BTI stock's market valuation is mixed, there is a case for a premium on the stock, and its dividend yield isn't bad either.
British American Tobacco p.l.c. (BTI) Q2 2026 Earnings Call Transcript
British American Tobacco NYSE: BTI said its first-half 2026 results were in line with expectations on a constant-currency basis, supported by growth in U.S. nicotine products, continued momentum for its Velo modern oral brand and resilient combustibles performance in the U.S. and AME region.
Cetera Investment Advisers grew its position in shares of British American Tobacco p.l.c. (NYSE: BTI) by 3.6% during the undefined quarter, according to the company in its most recent filing with the SEC. The firm owned 392,344 shares of the company's stock after purchasing an additional 13,488 shares during the quarter. Cetera Investment
The Dividend Income Accelerator Portfolio emphasizes high-quality companies with sustainable dividends, strong balance sheets, and attractive valuations to optimize risk-adjusted returns. I prioritize a diversified mix of ETFs and individual stocks across sectors, balancing dividend income, growth, and capital appreciation while mitigating downside risk. Key metrics include a 3.75% weighted average dividend yield, low payout ratios, and low beta factors, supporting long-term portfolio resilience.
Income investors hunting for yield have to look past headline sectors and focus on payout durability.
For nearly a decade, pension funds and major endowments blacklisted cigarette makers under strict sustainability mandates.
Core holdings for durable income compounding are likely to be boring. This is because there is no hype, no "once in a lifetime opportunities." Instead, it is all about stable earnings, well-capitalized balance sheets and, simply, a patient compounding.
British American Tobacco (BTI) is moving ahead with a major restructuring plan as the Dunhill cigarette maker works to cut costs and simplify its global operati
British American Tobacco on Monday said it will cut 5,500 jobs globally as it pushes ahead with its AI-driven transformation programme.
British American Tobacco is rapidly expanding its non-traditional products, particularly Velo nicotine pouches, driving strong adoption among younger users. BTI offers a compelling 5%+ dividend yield and is aggressively returning capital to shareholders through stock buybacks, enhancing total shareholder returns. With a forward P/E of 11.7x, BTI trades at a significant discount to industry peers, providing a high margin of safety for investors.
The U.S. Food and Drug Administration proposed a rule on Friday that would require foreign tobacco product makers to register their facilities and list products sold in the country.